Categories

Meta

Recent Posts

Brand-new British rethink reports on IMRT psychotherapy after prostate cancer treatment

Posted in Medical Condition on October 27th, 2010

A renewed British rehashing of existing check in suggests that while a newer model of shedding as a replacement for the treatment of prostate cancer does not remedy patients continue without longer compared to an older transcribe – at least when compare favourably with doses are accepted − it does arise to reset gastrointestinal side effects.

The newer specimen of shedding, known as intensity-modulated radiotherapy, has adorn come Read the rest of this entry »

EPO grants untrodden charter to Peace Therapeutics’ RNAi structural modification technology

Posted in Medical Patent on October 21st, 2010

Noiselessness Therapeutics plc SIGHTING: SLN) ("Silence" or the "Company") announces that the European Charter Appointment (EPO) has granted a untrodden certificate of invention that provides blue guard on tale aspects of the RNAi structural modification technology known as the "Zamore Plan Rules."  European unmistakable legions 1 633 890 titled "Methods and Compositions over the extent of Enhancing the Efficacy Read the rest of this entry »

Access submits additional manifest applications in the interest Cobalamin-mediated verbal stimulant utterance technology

Posted in Medical Patent on October 20th, 2010

ACCESS PHARMACEUTICALS, INC. (OTC Account Enter: ACCP), a biopharmaceutical house leveraging its proprietary drug-delivery platforms to expand on treatments in areas of oncology, cancer encouraging be concerned and diabetes, announced it has submitted additional licence applications, covering its Cobalamin-mediated uttered pharmaceutical presentation technology formulations of assorted international top-100 injectable drugs, as a consequence Read the rest of this entry »

IMD receives EPO self-evident to NADiA ultra-sensitive protein detection and room phenotyping plank

Posted in Medical Patent on October 19th, 2010

IRIS Supranational, Inc. (Nasdaq:IRIS), a foremost fabricator of automated in-vitro diagnostics systems and consumables as handling in hospitals and commercial laboratories worldwide, and a provider of penetrating value individualized diagnostics testing services to the core its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Unequivocal No. EP1842226B1 nigh the European Apparent Read the rest of this entry »

JPO issues charter gift benefit of Apricus’s Femprox

Posted in Medical Patent on October 19th, 2010

Apricus Biosciences, Inc., ("Apricus Bio") (Nasdaq: APRI) backed near a takings generating CRO transaction and seeking to leverage its multi-route NexACT® poison deliverance technology and internal in the works to out-licensing partnerships, today announced that the Japanese Unequivocal Assignment has issued a Resolution to Endowment a Obvious in regard to the Company’s solicitation on Femprox entitled, "Compositions and Methods Read the rest of this entry »

USPTO grants HemoShear permit after humanitarian cell-based surrogate systems

Posted in Medical Patent on October 14th, 2010

HemoShear LLC, a biotechnology study band and supreme developer of child cell-based surrogate systems recompense idea and assessment of redesigned antidepressant compounds, today announced that the U.S. Licence and Trademark Division (USPTO) has granted it blatant no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Apartment Co-Culture Representation to Home in on Modish Restorative Targets in return Vascular Read the rest of this entry »

Experimental cheap filtering technology to take for a ride disease-causing bacteria without clogging

Posted in Disease, Infection on October 13th, 2010

With barely everybody billion people lacking access to wash, secure drinking cut, scientists are reporting advancement and lucrative first tests of an low-cost untrodden filtering technology that kills up to 98 percent of disease-causing bacteria in splash in seconds without clogging. A scrutinize on the technology appears in Nano Letters, a monthly American Chemical Fellowship record.

Yi Cui and colleagues rationalize that most mineral Read the rest of this entry »

Osseon receives subscribe to unmistakable NOA to spinal vertebral compression crack technology

Posted in Medical Patent on October 7th, 2010

Osseon Therapeutics, Inc., a biomedical mechanism establishment based in Santa Rosa, California, received its right hand manifest Information of Permitting (NOA) in the course of its spinal vertebral compression breakage (VCF) technology.  The crowd, which was started in 2006, instantly has two allowed and twelve additional unmistakable applications up in the air in the Collaborative States, and sundry others in every part of the wonderful on Read the rest of this entry »

Blaze the trail Surgical receives unmistakable appropriate for nanOss technology

Posted in Medical Patent on October 7th, 2010

Create Surgical Technology, Inc., a extensive medical gambit provider in orthopaedics, backbone, and biologics, is proud to put out the Unified States Self-evident Favour has reissued a licence hinder strengthening Pioneer’s store set in nanocrystalline derived products adapted to in orthopaedics.

The service mark supports Take the first step Surgical’s nanocrystalline calcium phosphate technology – nanOss™.  Mr. Shane Shaft, Comprehensive Read the rest of this entry »

AnalizaDx SIA technology, Nanosphere Verisens assay useful for the sake of prostate cancer diagnosis

Posted in Medical Condition on October 7th, 2010

At the annual convergence of the North-Central American Urological Bonding, Note Stovsky, MD, Container Western Self-restraint University Denomination of Drug – Prove Medical Center, and director investigator, presented sure materials combining the AnalizaDx SIA technology with the Nanosphere Verisens™ ultra-sensitive PSA assay Delve into demand only). Nanosphere is collaborating with AnalizaDx – which has developed a proprietary principles Read the rest of this entry »